Chesapeake Perl Inc., of College Park, Md., named Tom Russo its chief financial officer.

The Global Alliance for TB Drug Development in New York appointed Ann Ginsberg head of clinical development.

Inspire Pharmaceuticals Inc., of Durham, N.C., appointed Richard Kent and re-elected Christy Shaffer to its board.

Memory Pharmaceuticals Inc., of Montvale, N.J., appointed Jzaneen Lalani vice president of legal affairs.

Millenia Hope Inc., of Montreal, appointed Wilfred Sylvain Nambei to its scientific committee.

MultiCell Technologies Inc., of Warwick, R.I., appointed Stephen Mon Wei Chang to its scientific advisory board.

Nanogen Inc., of San Diego, appointed David Ludvigson president and chief operating officer.

Neoprobe Corp., of Dublin, Ohio, appointed to its scientific advisory panel Kirby Bland, Kushagra Katariya, Edward Martin, Schlomo Schneebaum and Beat Walpoth.

PharmaNet, of Washington, appointed Duu-Gong Wu, senior director of PharmaNet Consulting.

Procyon Biopharma Inc., of Montreal, appointed Jinzi Wu vice president of preclinical and basic research.

RegeneRx Biopharmaceuticals Inc., of Bethesda, Md., appointed Paolo Carminati to its medical and scientific advisory board.

Valera Pharmaceuticals Inc., of Ranbury, N.J., appointed Pete Perron vice president of sales.